4//SEC Filing
Chawla Lakhmir S 4
Accession 0000920465-20-000124
CIK 0000920465other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:24 PM ET
Size
7.0 KB
Accession
0000920465-20-000124
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-07-31+581→ 581 totalExercise: $3.98Exp: 2030-07-31→ Common Stock (581 underlying) - Award
Common Stock
2020-07-31$3.38/sh+581$1,964→ 12,022 total
Footnotes (2)
- [F1]These shares were acquired on 07/31/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001646626
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:24 PM ET
- Size
- 7.0 KB